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ABSTRACT 
Objective: The aim of the present study was to formulate bromelain into nanoparticles in order to improve its stability and activity.  
Methods: Crude bromelain was prepared by protein precipitation from the pineapple stem juice using ammonium sulphate at the concentration of 
60% (w/v). Nanoparticles containing crude bromelain were generated using the ionic gelation method with hydroxypropyl cellulose–cysteamine 
(HPC-cysteamine) conjugate as a matrix. Crude bromelain was then added to the HPC-cysteamine solution for ionic interaction to construct the 
nanoparticles, which were then analyzed for their particle size and zeta potential. The resulting nanoparticles were mixed with adenosine 
diphosphate (ADP) to perform anti-platelet aggregation.  
Results: The nanoparticle had 928.3 nm in particle size and-7.25 mV in zeta potential. Anti-platelet activity of crude bromelain and the 
nanoparticles were determined with modification of light transmission aggregometry (LTA), in which ADP was used to induce an aggregation while 
a spectrophotometer UV-Vis was used to measure the absorbance at the wavelength of 600 nm. The result showed that crude bromelain and the 
nanoparticles rendered percentage inhibition of 8.00±1.17% and 48.56±11.19%, respectively.  
Conclusion: Based on the result of a one-way analysis of variance (ANOVA), it was concluded that there was a significant difference in percentage 
inhibition between the two samples. The nanoparticles demonstrated a better anti-platelet aggregation activity compared to crude bromelain. 
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INTRODUCTION 
Cardiovascular disease (CD) is caused by impaired heart function 
and blood vessels, one of which is coronary heart disease (CHD). 
Heart attacks occur when the damage is experienced by the heart 
muscle (myocardium) due to reduced blood supply to the heart 
muscle. A sudden drop in blood supply to the heart can occur when 
one of the coronary arteries is blocked due to blood clots and 
platelet aggregation. Many studies report that blockage of the brain 
and heart arteries often results from platelet hyperactivity that can 
increase platelet aggregation [1, 2]. 
In most cases, antiplatelets can cause aggregation inhibition. One 
of which is aspirin, but there have been some reports of the 
resistance to the use of aspirin as an antiplatelet. Aspirin, which 
belongs to the group of NSAIDs has side effects of irritation and 
even bleeding in the stomach [3-5]. One of the natural products 
found in Indonesia is pineapple (Ananas comosus (L.) Merr.) that 
contains vitamin A, vitamin C, beta-carotene, calcium, phosphorus, 
magnesium, iron, sodium, potassium and proteins in the form of 
bromelain enzymes. The health benefits of bromelain are to 
facilitate digestion, accelerate wound healing, treat burns and 
prevent tumor. The fiber content can facilitate defecation in 
patients with constipation [6]. 
Bromelain enzymes are mostly found in ripe pineapples compared 
to in immature green pineapples [7]. Pineapple stems are often 
thrown away because of the unpleasant taste, but they have the 
highest content of bromelain enzymes compared to the other parts 
[8]. Some types of pineapple which are widely available in Indonesia 
are Palembang, Bogor, and Subang pineapple. In a study conducted 
in 2010, the levels and protein activity of Palembang, Bogor, and 
Subang pineapple were compared to each other. The highest 
bromelain content with the highest activity was found in Palembang 
pineapple stems [9]. It was, therefore, the aim of this research to 
study the anti-platelet aggregation of crude bromelain entrapped 
within the nanoparticles based on HPC-cysteamine to reach the 
optimum activity and stability of bromelain in the biological system. 
MATERIALS AND METHODS 
Materials  
Palembang pineapple stem (Ananas comosus.(L.) Merr.) (the voucher 
specimen number is 2/DR/HLF/UP and the authentic number given by 
Research Center for Biology–LIPI is 2618/IPH.1.01/11.07/XII/2016), 
hydroxypropyl cellulose (HPC), cysteamine. HCl (Sigma Aldrich), MES (2-
(N-Morpolino) ethanesulfonic acid hydrate) (Sigma Aldrich), ammonium 
sulphate (Emsure), sodium periodate (Sigma Aldrich), sodium 
cyanoborohidride (Sigma Aldrich), Bradford reagent (Sigma Aldrich), 
adenosine diphosphate (ADP)(Helena Laboratories), sodium alginate 
(Sigma Aldrich), bovine serum albumin (BSA) and NaCl (Ecosol). 
Methods 
Synthesis of HPC-cysteamine 
1.5 g of HPC was dissolved in 20 ml of 96% ethanol and 120 ml of 
distilled water in erlenmeyer using a magnetic stirrer. The 
erlenmeyer was wrapped with aluminum foil and added to 800 mg 
of sodium periodate. The mixture was stirred for 3 h and added with 
200 µl of ethylene glycol to stop the reaction. The final mixture was 
purified in a dialysis tube for 3 d, and demineralized water for 
dialysis was replaced every 12 h. 1 g of oxidized HPC was dissolved 
in 40 ml aqua dest, 1 g MES buffer and 0.7 g cysteamine. HCl was 
added. pH value of the solution was adjusted to pH 5 and distilled 
water was added up to 50 ml. The mixture was stirred for 3 h and 4 
g of sodium cyanoborohydride was added and a permanent stirring 
was continued for 3 d. Afterward, the final mixture was purified with 
a dialysis tube for 3 d [10].  
Preparation of pineapple juice and crude bromelain 
Small pieces of pineapple stem were added with 0.1 M phosphate 
buffer pH 7 and milled using a blender. The suspension was filtrated 
and centrifuged at 3500 rpm for 15 min. The final filtrate was 
collected and added with a saturated ammonium sulphate solution 
to a final concentration of 60% (w/v) and stored overnight in the 
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refrigerator to precipitate crude bromelain. The centrifugation at 
2500 rpm for 20 min was carried out to obtain the precipitate, which 
was then dissolved in 0.1 M phosphate buffer pH 7. The solution was 
purified by a dialysis process in distilled water for 24 h. 
Determination of total protein content 
A standard protein solution was prepared by dissolving 0.2 g BSA in 
100 ml to obtain the stock solution in the concentration of 2000 
ppm. The solution was diluted to prepare a series of standard 
protein solutions with concentrations of 100, 200, 400, 600, 800, 
1000, and 1200 ppm. Afterward, 0.1 ml of each standard solution 
was added to 3.0 ml Bradford reagent, homogenized with a vortex, 
and incubated at room temperature for 45 min. The resulting 
solutions were measured using a UV-Vis spectrophotometer at a 
wavelength of 595 nm. 1 g of samples were dissolved in 10 ml of 0.1 
M phosphate buffer to reach a final concentration of 100 000 ppm. A 
sample solution was treated in the same manner as the standard 
solutions to assay the total protein content [11]. 
Preparation of nanoparticles containing crude bromelain based 
on HPC-cysteamine 
The stock solution of HPC-cysteamine 2% (w/v) was diluted with 
distilled water to obtain a concentration of 0.2% (w/v). 50 ml 0.2% 
of the solution was stirred with a magnetic stirrer. Afterwards, 20 ml 
crude bromelain solution was added dropwise. The formed 
nanosuspension was dried in a freeze dryer. Determination of 
particle size and polydispersion index was carried out by diluting 
the nanoparticles into distilled water with a ratio of 1:15 (v/v) at a 
temperature of 25 °C using particle size analyzer. The zeta potential 
test was performed by a zeta potential analyzer at a temperature of 
25 °C. The nanoparticles were diluted using distilled water before 
analysis and the conductivity of the solution was increased up to 
50µS/cm using a sodium chloride solution. The morphology of 
nanoparticles was performed using a transmission electron 
microscope (TEM).  
In vitro anti-platelet aggregation activity of the nanoparticles 
1 ml of platelet-rich plasma (PRP) was added to 4 ml of 0.9% NaCl 
(tube 1). 1 ml PRP was added to 1 ml of crude bromelain solution 
which was equivalent to 10 µg/ml bromelain (5000 ppm) and 3 ml 
of 0.9% NaCl (tube 2). 1 ml PRP was added to 1 ml of the 
nanoparticles suspension, which was equivalent to 10 µg/ml 
bromelain (6415 ppm) and 3 ml of 0.9% (w/v) NaCl (tube 3). 1 ml of 
platelet-poor plasma (PPP) was added to 1 ml of 2% (w/v) HPC-
cysteamine which was equivalent to the amount of HPC-cysteamine 
in tube 3 (2475 ml) and 1525 ml of 0.9% (w/v) NaCl (tube 4). 1 ml 
PPP was added to 4 ml 0.9% NaCl (tube 5). Tube 1, 2, 3, 4, and 5 
were incubated at 37 °C for 30 min, then 20 µl 10 µM ADP was 
added, then incubated for 20 min at 37 °C. Tube 1 served as a 
negative control and tube 5 as a blank for tube 1 and 2, while tube 4 
as a blank for tube 3. The absorbance of the solution in tubes 1, 2 
and 3 were measured by UV-Vis spectrophotometer at a wavelength 
of 600 nm, then the percentage of anti-platelet aggregation activity 




 x 100%. . (1) 
where Abs is absorbance [12, 13]. 
RESULTS AND DISCUSSION 
Synthesis of HPC-cysteamine 
After the oxidation, the generated aldehyde could be further 
oxidized to a carboxylic acid group; thus, ethylene glycol was added 
to end the reaction. The low viscosity was examined to presume the 
presence of the aldehyde. The conjugation cysteamine to the 
aldehyde was stabilized by sodium cyanoborohydride (NaCNBH3) as 
a reducing agent because of the stability in relatively strong acidic 
conditions (~ pH 3) and different selectivity at different pHs. In this 
study, the reaction was in the acid condition to immobilize a high 
amount of free thiol groups [14]. Based on the previous studies, the 
conjugate displayed the amount of free thiol groups of 
1063.03±64.27 μmol/g using Ellman’s reagent [15]. At pH 8 the 
reaction did not occur at all. By using the same procedure, the 
amount of free thiol groups of chitosan-mercaptoethylamine was 
1878±70 μmol per gram of polymer [16]. Thereby, the procedure 
demonstrated a high coupling rate for both HPC and chitosan.  
Preparation of pineapple juice and crude bromelain 
Bromelain in the small cut of pineapple stem was stabilized in 0.1 M 
phosphate buffer pH 7 at a temperature of 4 °C to preserve its activity. 
The optimum pH of the bromelain enzymes was maintained to avoid 
the change in groups with ions in the active site of bromelain. The 
precipitation of bromelain with a saturated solution of ammonium 
sulphate was based on the process of salting-out. In order to take out 
bromelain from the stem juice, the choice of buffer systems used was 
crucial. The components in the stem should be compatible with those 
in the buffer to keep the biological activity of bromelain. Therefore, ion 
concentration and ionic strength in the buffer played an important 
rule. Since bromelain has a molecular weight of 33.5 kDa, bromelain 
was trapped in the membrane tube while phosphate buffer and 
ammonium sulphate were displaced from it [17-19].  
Determination of total protein content 
The absorbance for the standard curve was obtained after the reaction 
based on the Bradford method. The resulting absorbance can be seen 
in table 1. The reaction caused the red form of the dye Coomassie 
Brilliant Blue G-250 was converted into its blue form under acidic 
conditions. The crude bromelain obtained after freeze-drying was 
rather moist, which indicated the water content was quite high 
whereas its protein content was very small (0.2% w/w). The dye can 
bind to the amino acid residues in the protein present in the sample. In 
addition, hydrophobic and ionic interaction can play an important role 
in the reaction. They stabilize the reaction to display a visible color 
change which can be spectrophotometrically measured [20, 21]. 
  
Table 1: Absorbance of BSA 
BSA concentration (ppm) Absorbance 
100 0.1258 
 200 0.1788 
400 0.3746  
500 0.4297 
700 0.5608 
800  0.5927 
  
Preparation of nanoparticles containing crude bromelain based 
on HPC-cysteamine 
In most cases of the synthesis methods of polymeric nanoparticles, a 
crosslinker is acquired. The buffer containing negatively charges of 
phosphate ions could act as a crosslinker. The buffer was originated from 
crude bromelain solution and was still present after the freeze-drying.  
The formation of nanoparticles occured when the turbidity was 
visually observed without any sedimentation. The turbidity 
describes the number of nanoparticles, while the sedimentation 
shows the unstability of nanoparticles. The mixture of HPC-
cysteamine and crude bromelain was already turbid; thus, there was 
no need to add a crosslinker to generate the nanoparticles [15]. 
The nanoparticles was a translucent liquid that demonstrated the 
presence of colloid system. Since in the preparation of crude 
bromelain, phosphate buffer had been included, the resulting crude 
bromelain contained phosphate ions which have negatively charged 
Rahmat et al. 
Int J App Pharm, Vol 12, Issue 3, 2020, 95-98 
97 
ions like those in sodium tripolyphosphate. Hence, they could act as 
a crosslinker in the preparation of the nanoparticles.  
Particle size and zeta potential evaluation are necessary to determine the 
characterization and to predict the stability of nanoparticles. The 
nanoparticles demonstrated that their particles size and zeta potential 
were 928.3±41.40 nm and-7.25±3.95 mV, respectively. The 
measurement of particle size of nanoparticles was divided into 3 types, 
which were based on number, intensity, and volume. Measurement-
based on quantities is intended to group and counts the number of 
particles based on the differences in size. Measurement-based on volume 
is aimed to investigate the volume occupied by each group with different 
particle sizes. Measurement-based on intensity is performed to collect 
the light refracted by each group with different particle sizes. 
The presence of crude bromelain, which has a large molecular weight in 
the nanoparticles caused the particles size were large and almost micro 
scale. In addition, the particle size could be interfered by the presence of 
phosphate buffer in crude bromelain, which is not a polyanion. 
Molecules that have polyanions such as sodium tripolyphosphate could 
form the smaller size of nanoparticles because one molecule of which 
has many anions thus has a greater opportunity to associate with more 
amine groups in HPC-cysteamine as a cationic thiomer. 
 
 
Fig. 1: Morphology of the nanoparticles using TEM 
The small polydispersity index shows a narrow particle size 
distribution. The nanoparticles formed had a polydispersity index of 
0.480. This shows that the nanoparticles had a uniform size. The 
uniformity is very important because it will affect the uniformity of 
the biological activity of the nanoparticles. The higher zeta potential 
will result in a greater repulsive force between nanoparticles, which 
means that the nanoparticles are more stable. The nanoparticles had 
a negatively charge of zeta potential because crude bromelain was 
attached by negatively charged phosphate ions, which were derived 
from the buffer used during the isolation. 
In vitro anti-platelet aggregation activity of the nanoparticles  
The study of anti-platelet aggregation activity used LTA (light 
transmission aggregometry) method with a slight modification. The 
method still refers to the principle of turbidimetry, and the tool used 
to measure the turbidity was UV-Vis spectrophotometer at a 
wavelength of 600 nm instead of an aggregometer. The blank 
solution for the test contained PPP, which was added to HPC-
cysteamine as a thiomer. Blood plasma contains albumin, globulin, 
and fibrinogen. To obtain the plasma, a centrifugation technique was 
required at 3000 rpm for 15 min. Platelets could be present in the 
plasma components because of their small size. Hence, PPP served 
as a blank to compensate for the turbidity from plasma components. 
The anti-platelet aggregation activity of crude bromelain and the 
nanoparticles were described by percentage inhibition calculated 
from the decrease in the absorbance of negative controls, which 
showed a decrease in platelet aggregation. PRP was incubated with 
the samples and its aggregation was induced by ADP. The inhibition 
percentage of platelet aggregation produced by each sample against 
ADP can be seen in table 2 and 3.  
In normal circumstances, platelet aggregation prevents bleeding in 
the body. However, aggregates can be formed even though there are 
no vascular injuries; such aggregates are called a pathological 
thrombus. The bromelain enzymes belongs to the sulfhydryl group 
which is able to hydrolyze proteins into amino acids and can reduce 
platelet sensitivity to ADP [22-24]. 
 
Table 2: Crude bromelain activity in inhibition of platelet aggregation 
Sample PRP* PRP+Crude bromelain* 
Absorbance Absorbance % Inhibition 
I 0.4137 0.3815 7.78% 
II 0.3628 0.3282 9.54% 
III 0.3422 0.3193 6.69% 
Average 8.00±1.17% 
Notes: *: Data represented as mean±SD (n=3) and PPP as a blank 
 
Table 3: The nanoparticles activity in inhibition of platelet aggregation 
Sample PRP PRP+The nanoparticles* 
Absorbance Absorbance % Inhibition 
I 0.2273 0.0895 60.62% 
II 0.2140 0.1040 51.40% 
III 0.2220 0.1473 33.65% 
Average 48.56±11.19 
Notes: *: Data represented as mean±SD (n=3) and the mixture of PPP and the thiomer as a blank 
 
The results showed that crude bromelain could inhibit platelet 
aggregation as the decrease in the absorbance of PRP occured. 
Bromelain can inhibit platelet aggregation because it can cut off the 
fibrin bridge formed when platelets aggregate [4]. The nanoparticles 
could increase the anti-platelet aggregation activity of crude 
bromelain as the decrease in the absorbance of PRP incubated with 
the nanoparticles, was greater compared to those incubated with 
crude bromelain.  
Polymeric nanoparticles with free thiol groups can improve the 
attachment of a loaded drug on the gastrointestinal mucus 
consisting of mucin glycoproteins through the formation of disulfide 
bonds [10, 25]. In the case of the platelets, the sulfhydryl groups on 
the surface of nanoparticles support the attachment of the 
nanoparticles on the platelet glycoprotein receptors through the 
formation of disulfide bonds. Hence, ADP could not reach the 
receptors; thus, platelet activation was inhibited. In addition, 
bromelain could cut off fibrin bridges between aggregated platelets. 
Hence, the anti-platelet aggregation activity of the nanoparticles was 
greater than that of crude bromelain. The activity of bromelain 
within the nanoparticles was protected due to the presence of strong 
disulfide bonds. Moreover, the disulfide bonds could control the 
release of bromelain to prolong its activity [10, 26-29].  
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CONCLUSION 
Crude bromelain could be entrapped within the nanoparticles, which 
was prepared by ionic gelation method. The nanoparticles were 
based on HPC-cysteamine as a thiomer, which has free thiol groups. 
The properties of the thiomers might influence the increase in the 
activity of anti-platelet aggregation of bromelain within the 
nanoparticles. Thereby, nanoparticles based on HPC-cysteamine 
could be a potential platform for therapeutic proteins delivery. 
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